Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 89.27 USD -0.97%
Market Cap: 5.7B USD
Have any thoughts about
Blueprint Medicines Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Blueprint Medicines Corp

Current Assets 903.5m
Cash & Short-Term Investments 763.6m
Receivables 85.1m
Other Current Assets 54.9m
Non-Current Assets 300m
Long-Term Investments 104.9m
PP&E 109m
Other Non-Current Assets 86.1m
Current Liabilities 243.8m
Accounts Payable 4.9m
Accrued Liabilities 133.2m
Other Current Liabilities 105.7m
Non-Current Liabilities 639.5m
Long-Term Debt 338.7m
Other Non-Current Liabilities 300.9m

Balance Sheet
Blueprint Medicines Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
47
163
52
400
68
114
685
210
120
71
Cash Equivalents
47
163
52
400
68
114
685
210
120
71
Short-Term Investments
0
0
162
273
426
370
187
267
825
639
Total Receivables
0
3
4
0
0
23
25
37
37
43
Accounts Receivables
0
3
4
0
0
23
25
37
37
43
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
9
22
30
21
Other Current Assets
1
4
3
12
6
10
22
18
35
33
Total Current Assets
48
170
220
686
500
517
928
554
1 047
808
PP&E Net
2
7
6
24
30
111
102
121
115
116
PP&E Gross
2
7
6
24
30
111
102
121
115
116
Accumulated Depreciation
2
2
3
5
9
14
20
25
31
38
Long-Term Investments
0
0
54
0
0
64
678
558
134
57
Other Long-Term Assets
0
2
2
6
11
15
11
20
55
69
Total Assets
50
N/A
179
+259%
283
+58%
716
+153%
540
-25%
708
+31%
1 718
+143%
1 252
-27%
1 350
+8%
1 049
-22%
Liabilities
Accounts Payable
1
3
2
4
3
5
4
8
3
5
Accrued Liabilities
4
6
12
31
52
96
114
130
142
140
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
3
3
2
0
0
0
0
17
30
Other Current Liabilities
0
7
12
7
5
6
13
12
22
40
Total Current Liabilities
7
19
29
43
60
107
131
150
183
215
Long-Term Debt
7
4
2
0
0
0
0
0
122
209
Other Liabilities
0
12
40
49
61
137
118
132
530
495
Total Liabilities
15
N/A
35
+141%
70
+100%
92
+32%
121
+32%
243
+101%
248
+2%
282
+13%
835
+197%
919
+10%
Equity
Common Stock
115
0
0
0
0
0
0
0
0
0
Retained Earnings
82
135
208
356
598
945
631
1 275
1 833
2 340
Additional Paid In Capital
3
279
421
980
1 017
1 412
2 107
2 250
2 358
2 474
Other Equity
0
0
0
0
0
3
5
4
10
3
Total Equity
35
N/A
144
+307%
213
+48%
624
+193%
419
-33%
464
+11%
1 470
+217%
971
-34%
515
-47%
131
-75%
Total Liabilities & Equity
50
N/A
179
+259%
283
+58%
716
+153%
540
-25%
708
+31%
1 718
+143%
1 252
-27%
1 350
+8%
1 049
-22%
Shares Outstanding
Common Shares Outstanding
26
27
33
44
44
49
58
59
60
61

See Also

Discover More